High ablative single doses (> 20 Gy), such as those delivered by SABR/SBRT have been shown to dramatically increase T cell priming, CD8 + T cell infiltration and the induction of tumour regression in breast, lung and melanoma mouse models [36, 37]. Here, CD8A is linked to neoplasm.